These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 31897145)

  • 21. ENPP2 protects cardiomyocytes from erastin-induced ferroptosis.
    Bai YT; Chang R; Wang H; Xiao FJ; Ge RL; Wang LS
    Biochem Biophys Res Commun; 2018 Apr; 499(1):44-51. PubMed ID: 29551679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival data for postoperative adjuvant chemotherapy comprising cisplatin plus vinorelbine after complete resection of non-small cell lung cancer.
    Kenmotsu H; Ohde Y; Wakuda K; Nakashima K; Omori S; Ono A; Naito T; Murakami H; Kojima H; Takahashi S; Isaka M; Endo M; Takahashi T
    Cancer Chemother Pharmacol; 2017 Sep; 80(3):609-614. PubMed ID: 28761967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MCL1 inhibition: a promising approach to augment the efficacy of sorafenib in NSCLC through ferroptosis induction.
    Huang CY; Chen LJ; Chen CS; Wang CY; Hong SY
    Cell Death Discov; 2024 Mar; 10(1):137. PubMed ID: 38485916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines.
    Zheng J; Sato M; Mishima E; Sato H; Proneth B; Conrad M
    Cell Death Dis; 2021 Jul; 12(7):698. PubMed ID: 34257282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells.
    Geng N; Shi BJ; Li SL; Zhong ZY; Li YC; Xua WL; Zhou H; Cai JH
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3826-3836. PubMed ID: 29949159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4-mediated ferroptosis.
    Pan X; Lin Z; Jiang D; Yu Y; Yang D; Zhou H; Zhan D; Liu S; Peng G; Chen Z; Yu Z
    Oncol Lett; 2019 Mar; 17(3):3001-3008. PubMed ID: 30854078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irisin Is a Positive Regulator for Ferroptosis in Pancreatic Cancer.
    Yang BC; Leung PS
    Mol Ther Oncolytics; 2020 Sep; 18():457-466. PubMed ID: 32953980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
    Su J; Zhang F; Li X; Liu Z
    Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells.
    Battaglia AM; Sacco A; Perrotta ID; Faniello MC; Scalise M; Torella D; Levi S; Costanzo F; Biamonte F
    Front Oncol; 2022; 12():868351. PubMed ID: 35433479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors.
    Lachaier E; Louandre C; Godin C; Saidak Z; Baert M; Diouf M; Chauffert B; Galmiche A
    Anticancer Res; 2014 Nov; 34(11):6417-22. PubMed ID: 25368241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic identification of a nuclear receptor-enriched predictive signature for erastin-induced ferroptosis.
    Kwon OS; Kwon EJ; Kong HJ; Choi JY; Kim YJ; Lee EW; Kim W; Lee H; Cha HJ
    Redox Biol; 2020 Oct; 37():101719. PubMed ID: 32979793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of Metformin and Sorafenib Induces Ferroptosis of Hepatocellular Carcinoma Through p62-Keap1-Nrf2 Pathway.
    Tang K; Chen Q; Liu Y; Wang L; Lu W
    J Cancer; 2022; 13(11):3234-3243. PubMed ID: 36118519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspirin plus sorafenib potentiates cisplatin cytotoxicity in resistant head and neck cancer cells through xCT inhibition.
    Roh JL; Kim EH; Jang H; Shin D
    Free Radic Biol Med; 2017 Mar; 104():1-9. PubMed ID: 28057599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways.
    Zhu B; Ren C; Du K; Zhu H; Ai Y; Kang F; Luo Y; Liu W; Wang L; Xu Y; Jiang X; Zhang Y
    Biochem Pharmacol; 2019 Dec; 170():113642. PubMed ID: 31541631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ferroptosis inducer erastin irreversibly inhibits system x
    Sato M; Kusumi R; Hamashima S; Kobayashi S; Sasaki S; Komiyama Y; Izumikawa T; Conrad M; Bannai S; Sato H
    Sci Rep; 2018 Jan; 8(1):968. PubMed ID: 29343855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. xCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers.
    Lee N; Carlisle AE; Peppers A; Park SJ; Doshi MB; Spears ME; Kim D
    Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33672555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
    Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R
    Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells.
    Hao S; Yu J; He W; Huang Q; Zhao Y; Liang B; Zhang S; Wen Z; Dong S; Rao J; Liao W; Shi M
    Neoplasia; 2017 Dec; 19(12):1022-1032. PubMed ID: 29144989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
    Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
    Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.